Prolactin Receptor Antagonists That Inhibit the Growth of Breast Cancer Cell Lines
Open Access
- 1 June 1995
- journal article
- Published by Elsevier
- Vol. 270 (22) , 13133-13137
- https://doi.org/10.1074/jbc.270.22.13133
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- [19] Rapid and efficient site-specific mutagenesis without phenotypic selectionPublished by Elsevier ,2004
- Rational Design of Potent Antagonists to the Human Growth Hormone ReceptorScience, 1992
- Dimerization of the Extracellular Domain of the Human Growth Hormone Receptor by a Single Hormone MoleculeScience, 1991
- The epidemiology of breast cancerCA: A Cancer Journal for Clinicians, 1991
- Rational design of receptor-specific variants of human growth hormone.Proceedings of the National Academy of Sciences, 1991
- Zinc Mediation of the Binding of Human Growth Hormone to the Human Prolactin ReceptorScience, 1990
- Identification of a cDNA Encoding a Long Form of Prolactin Receptor in Human Hepatoma and Breast Cancer CellsMolecular Endocrinology, 1989
- Multihormonal Regulation of Insulin-Like Growth Factor-I-Related Protein in MCF-7 Human Breast Cancer CellsMolecular Endocrinology, 1988
- Characterization of lactogen receptors in lactogenic hormone-dependent and independent NB2 lymphoma cell linesFEBS Letters, 1987
- A Specific Growth Hormone-Binding Protein in Human Plasma: Initial Characterization*Journal of Clinical Endocrinology & Metabolism, 1986